Kilitch Drugs India
BSE 524500
3 stories, newest first.
- EGM on 16 Nov 2026 to vote on sale of entire stake in Ethiopian subsidiary, debt conversion, 2 director appointments
- Kilitch Drugs to divest Ethiopian subsidiary Kilitch Estro Biotech to HarmeeCare for US$14 million; plans new Pen facility
- Board approves divestment of 100% stake in Ethiopian material subsidiary, conversion of INR 57.00 Crores debt
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.